Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
PharmaShots CXO Talks | Women’s History Month Special: A Conversation with Dr. Emanuela Offidani of Tris Pharma
Dr. Emanuela Offidani, Tris Pharma’s Medical Director of Digital Health Strategy, highlighted that ADHD is increasingly recognized as a lifelong condition that often goes undiagnosed in women because symptoms are less overt. She explained that Tris Pharma’s proprietary LiquiXR delivery platform provides smoother, sustained drug release, aiming to improve adherence and therapeutic outcomes. The conversation also covered the company’s expanding pipeline of digital therapeutics and its use of AI, wearables, and digital diagnostics to enhance ADHD detection and personalized care. Offidani emphasized the synergy between technology and clinical expertise for long‑term patient management.
Gen Z Drives Historic $830B Alcohol Market Collapse
Over the past four years, alcohol companies have collectively lost $830 billion in market value—with Gen Z emerging as a major driver. U.S. adult drinking rates have dropped to just 54%, the lowest level since tracking began in 1939, This shift comes...
Sharp HealthCare’s Korn Says Spatial Computing Gives Clinicians Superpowers, But Demands a Strong IT Foundation
In this episode, Dr. Tommy Korn, Sharp Healthcare’s Chief Spatial Computing Officer and practicing ophthalmologist, explains how the health system is leveraging Apple Vision Pro devices to give clinicians "superpowers" through spatial computing. He outlines the dual role of his...
Study Finds Midlife Women Face Unprecedented Stress Levels, Threatening Health of Millions
A joint study by the American Psychological Association, Harvard Health Publishing and the National Institute on Aging released data showing an unprecedented stress surge among women aged 35‑54. The findings link chronic pressure to fatigue, anxiety, sleep problems and heightened...
Personalized Rehab Solution: Supporting Patients With Work Responsibilities
Personalized rehabilitation programs are emerging to accommodate clients who cannot abandon work responsibilities. Facilities like Tranquil Shores offer flexible scheduling, remote therapy, and tailored treatment plans that align with individual career demands. By integrating technology and confidential care, these programs...
3 Ways Self-Employed Healthcare Professionals Can Reduce Admin Time
Self‑employed healthcare professionals are spending an outsized portion of their week on administrative tasks, from chasing payments to handling complex tax filings. The article outlines three practical ways to cut that burden: systematically tracking how time is spent, leveraging modern...
Corcept Therapeutics Shares Surge 20% on FDA Approval of Lifyorli
Corcept Therapeutics saw its shares climb almost 20% after the U.S. FDA approved its lead drug Lifyorli in combination with nab‑paclitaxel for platinum‑resistant ovarian, fallopian tube and primary peritoneal cancer. The approval, based on a 381‑patient trial, validates the company's...
House Democrats Accuse CMS Official of Misleading Congress Under Oath
House Democrats allege CMS COO Kimberly Brandt gave misleading testimony under oath about the agency’s efforts to engage Minnesota before withholding Medicaid funds. Brandt claimed litigation blocked a hearing, yet she later asked the hearing to be stayed, prompting Rep....
$50 Billion Rural Hospital Fund Sparks Fears of More Closures
The U.S. government unveiled a $50 billion Rural Hospital Sustainability Fund, but health‑policy experts warn the money could unintentionally hasten hospital closures and reduce access to care in underserved areas.
Acting CDC Director Jay Bhattacharya Vows Stability as Agency Grapples with Leadership Crisis
Acting CDC Director Jay Bhattacharya told staff he will steer the agency toward stability after a year of mass layoffs, a shooting, and a leadership vacuum. He pledged to fill acting roles, depoliticize operations and restore morale as the 210‑day...
Michigan Spent $82M on Medicaid Contract With Little Oversight, Audit Finds
A Michigan state audit uncovered that the Department of Health and Human Services failed to adequately monitor an $82 million contract with Prime Therapeutics State Government Solutions, a pharmacy‑benefits manager for Medicaid. Over a seven‑and‑a‑half‑year period, oversight relied heavily on the...
Precigen Posts 149% Revenue Surge, Forecasts $18M Q1 as Papzimius Gains Momentum
Precigen (PGEN) reported fiscal Q4 2025 revenue of $9.7 million, up 149% year‑over‑year, and projected first‑quarter 2026 sales to exceed $18 million. The surge stems from the rapid commercial rollout of its FDA‑approved gene‑therapy Papzimius and broader payer coverage across the United...
How ChatGPT Health Exposes the Flaws in Modern Primary Care
OpenAI launched ChatGPT Health, a consumer AI that can ingest medical records, wearable data, and personal health history to give real‑time, context‑aware guidance. The platform serves 230 million weekly users asking health questions, exposing how primary‑care systems have failed to provide...
An Expanding Problem: Fraud and Compliance Challenges in Bone Growth Stimulators
Bone‑growth stimulators, classified as Class III devices, sit at a volatile crossroads of reimbursement rules, medical necessity, and aggressive marketing. Recent enforcement actions reveal kickback schemes disguised as personal service agreements and template‑billing practices that generated over $1.1 million in fraudulent claims...
Calling It GLP‑3 Reveals Ignorance of Triple Agonists
If you use the terminology “GLP-3” instead of GLP-1/GIP/Glucagon receptor agonist or at least triple agonist, I’m going to assume you don’t know much about these medicines.
Exercise Beats Optional: Key for Prostate Cancer Survival
As a medical school professor, I can tell you: the textbooks got this one wrong. We taught that once you have prostate cancer, exercise is nice but optional. New data says it may be the most powerful tool in your arsenal. 828...
Atrial Septal Defect Assessment with Echocardiography
The Echo Journal outlines a systematic approach to assessing atrial septal defects (ASDs) using echocardiography, emphasizing the three anatomical regions of the interatrial septum—central, inferior, and superior. It details how each region correlates with specific defect types, such as ostium...
Novocure Reports Topline P-II (PANOVA-4) Trial Data on TTFields Therapy for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Novocure disclosed topline Phase‑2 PANOVA‑4 data showing that Tumor‑Treating Fields (TTFields) combined with Tecentriq and gemcitabine/nab‑paclitaxel achieved a 74.4% disease‑control rate in metastatic pancreatic ductal adenocarcinoma (mPDAC). The trial, enrolling 78 patients, outperformed the historical MPACT control arm’s 48% DCR. Secondary...
EPtalk by Dr. Jayne 3/26/26
Epic Systems remains the dominant electronic health record (EHR) vendor, powering more than 250 U.S. hospitals, but its market grip faces mounting criticism over cost, complexity, and data‑privacy practices. A Texas‑filed lawsuit, spearheaded by the state Attorney General, alleges Epic’s...
Ill. FD Takes over Ambulance Service for Neighboring Fire District
Starting July 1, the Lexington Fire Protection District will become the primary ambulance provider for the neighboring Octavia Fire Protection District, delivering basic life support services staffed by licensed EMTs. The agreement covers the communities of Anchor, Cropsey, Colfax and Cooksville....
Military Medics Trial AI for the Battlefield
The UK Defence Science and Technology Laboratory teamed with the US DARPA under the In the Moment program to test AI‑aligned battlefield medical triage. Trials in October 2025 at Merville Barracks and Brize Norton used VR scenarios where AI mimicked a...
Vitamins B3 Plus B6 May Boost Muscle Repair After High Intensity Exercise: Nestlé Study
A Nestlé‑backed randomized trial gave healthy men 714 mg nicotinamide and 19 mg pyridoxine daily for nine days after intense eccentric exercise. The B‑vitamin combo boosted muscle stem cell numbers by 29% and accelerated differentiation markers—MyoD+ cells rose 67%, myogenin+ cells 34%,...
Menopause Claims Back Under the Spotlight Following ASA Review
The UK Advertising Standards Authority (ASA) has flagged three menopause‑focused supplement brands—Lunera, Minerva Wellness and Nova—for making unauthorized health claims in paid social media ads. The advertisements suggested the products could treat menopause symptoms such as weight gain, hot flushes,...
Oral Peptides Biotech Pinnacle Medicines Gets $89M From US, China Investors
Pinnacle Medicines, a two‑year‑old biotech focused on oral peptide therapeutics, secured $89 million from a mix of U.S. and Chinese investors. The financing will fund its platform that converts injectable peptides into pill form, building on the recent success of Novo...
6 Recommendations for PBM Procurement and Rx Benefits Optimization
The 2026 pharmacy benefit manager (PBM) RFP season is shaping up to be one of the most consequential for employers, driven by sweeping state and federal reforms and soaring healthcare costs. Nearly two‑thirds of plan sponsors are already considering alternatives...
DDW Highlights: 26 March 2026
In this episode, Bruno Quinney highlights three breakthrough studies: Edinburgh researchers engineered E. coli to convert PET plastic waste into the Parkinson's drug L‑DOPA, offering a sustainable route to a vital medication; scientists identified the enzyme DHX8 as a key...
Otsuka Pharmaceutical Reports P-III (VISIONARY) Trial Data on Voyxact for IgA Nephropathy (IgAN)
Otsuka Pharmaceutical presented Phase III VISIONARY trial data for Voyxact (sibeprenlimab‑szsi) in IgA nephropathy patients at risk of progression. At 48 weeks, 82.5% of patients receiving 400 mg subcutaneous Voyxact achieved negative microscopic hematuria versus 52.6% on placebo, with median time to...
Development of an Ultra-Sensitive Human Cardiac Troponin I Sandwich ELISA
Exazym®'s BOLD amplification technology boosts the sensitivity of a human cardiac troponin I sandwich ELISA by 180‑fold, lowering the detection limit to 0.07 pg/mL. The webinar presented by Cavidi’s Peter Stenlund shows how the method integrates into standard ELISA workflows with...
International Menopause Society Sets New Global Standards for Menopause Care with Evidence-Led Framework
The International Menopause Society (IMS) has issued its first comprehensive overhaul of global menopause guidelines since 2016, delivering an evidence‑led framework developed by 38 experts and 27 contributors. The live, updateable document spans 30 sections covering symptoms, cardiometabolic health, bone...
India's Health Insurance Premiums Cross ₹1.2 Lakh Crore in 2024-25: Finance Ministry
India's health‑insurance premiums surged past ₹1.2 lakh crore (≈ $14.5 billion) in FY 2024‑25, marking a 9% year‑on‑year increase. The Insurance Regulatory and Development Authority of India (IRDAI) introduced tighter cashless claim timelines—one hour for pre‑authorisation and three hours for final approval—to speed...
Pediatric Home Health Care Oversight: Why Accountability Is Failing
The article exposes a systemic failure of accountability in pediatric home health care, where state caps on nursing hours leave families to shoulder massive unpaid caregiving burdens. Reporting serious safety violations to nursing boards often results in silence, highlighting a...
Geopolitics and Drug Shortages
The escalation of the Iran conflict has throttled traffic through the Strait of Hormuz and crippled Gulf airport capacity, exposing a fragile pharmaceutical distribution network that relies on the Dubai hub. Air‑cargo rates are soaring while the region’s ability to...
Laudio and AONL Report Reveals Distinct Expectations and Work Patterns Among Gen Z in the Healthcare Workforce
The Laudio and AONL Spring 2026 report, based on a national dataset of nearly 100,000 RNs, shows Generation Z is the fastest‑growing nursing cohort and the only one still expanding. Gen Z nurses demand 2.5 times more frequent, meaningful manager interactions and...
Midlife Metabolism Shifts Demand New Weight‑Loss Strategies
A lot of midlife women are not failing weight loss advice. They are following advice that may be physiologically mismatched to this stage of life. In this episode of The Podcast by KevinMD, Marsha Shepherd Whitt challenges a message clinicians and patients...
Healthcare Shifts to Homeownership, Burdening the Poor
The healthcare model moves to homeownership. Higher premiums for lower coverage. Now let's pause to consider who this adversely impacts the most. I suppose we should take consolation in the fact that those at the bottom were already priced out of home ownership.
The Doctor Behind One of Canada’s First MAID Deaths Speaks Out
In 2024 Canada recorded 16,499 medically assisted deaths, with Quebec responsible for more than a third of the total. The majority (99.99%) were active euthanasia cases using a three‑drug protocol, making MAID the fourth leading cause of death after cancer,...
Anti‑TGFβ1 Antibody Shows Durable Efficacy, Low Toxicity
Scholar Rock's anti-TGFb1 antibody clinical study with early data in oncology indications... minimal AEs and signs of durable efficacy in checkpoint-refractory patients. $SRRK https://t.co/8xsN4wtbMV
Measles Outbreak From Detention Center Spreads to Texas
Measles in federal detention facility reaches the Texas public. My comments with @alexnguyen2311 @TexasTribune https://t.co/zaqrcEa4rC
Autoimmune Immunotherapy Is Shifting Upstream: AnaptysBio on Targeting Pathogenic Immune Cells
Autoimmune drug development is moving upstream, targeting pathogenic immune cells rather than single cytokines. AnaptysBio’s Chief Medical Officer, Paul Lizzul, highlighted the company’s cell‑selective immunomodulation strategy, including CD122 antagonism that modulates both CD4 helper and CD8 cytotoxic T cells. Early‑phase...
Kallisio’s Stentra Receives CE Mark for Precision Oral Immobilization System in Head & Neck Radiation Therapy
Swiss‑based Kallisio has secured CE certification for its Stentra intraoral positioning system under the EU Medical Device Regulation 2017/745. The device, a patient‑specific 3‑D‑printed oral immobilizer, improves millimeter‑level accuracy in head‑and‑neck radiation therapy without altering existing treatment planning software or...
Senate Advances Bill to Fund Psychedelic Trials for Veterans' Mental Health
The U.S. Senate has advanced legislation that would fund expanded clinical trials of psychedelic therapies for veterans suffering from PTSD, depression and traumatic brain injury. The bill, backed by a bipartisan coalition, marks the first federal effort to systematically study...
Researchers Push FDA to Adopt Simpler “High‑In” Front‑of‑Package Labels
A new UC Davis study of more than 13,000 U.S. adults shows that simple “high‑in” front‑of‑package labels help consumers spot added sugar, sodium or saturated fat faster than the FDA’s proposed low/medium/high rating box. The findings intensify calls for the agency...
Eli Lilly’s Triple‑Agonist Retatrutide Cuts A1C 2% and Weight 17% in Phase III
Eli Lilly announced top‑line results from the Phase III TRANSCEND‑T2D‑1 trial, showing its investigational triple‑hormone agonist retatrutide reduced HbA1c by up to 2 percentage points and produced an average 16.8 % weight loss over 40 weeks. The data position retatrutide as a potential...
Atossa Therapeutics Posts Q4 2025 Results, Secures Rare Disease Designations for (Z)-Endoxifen
Atossa Therapeutics released its fourth‑quarter 2025 earnings and announced that the FDA granted Rare Pediatric Disease and Orphan Drug designations to its lead candidate (Z)-endoxifen for Duchenne muscular dystrophy. The company said the designations accelerate its rare‑disease strategy while it...
New Horizon Medical Solutions Names Dr. Christine Grogan as Chief Commercial Officer
New Horizon Medical Solutions announced the appointment of Dr. Christine Grogan as Chief Commercial Officer, tasking her with expanding sales, marketing and partnership initiatives. The move underscores the fast‑growing health‑tech firm’s push to scale commercial operations amid rising demand for...
Dyadic COO Hazelton Steers Modest $3.1M Revenue Rise Amid Grant‑driven Cost Shift
Dyadic (DYAI) posted Q4 2025 revenue of $3.1 million, a modest rise driven by COO Joseph P. Hazelton’s operational focus. The earnings call highlighted new product launches, global distribution deals and a growing reliance on grant‑linked R&D, offsetting a drop in...
Drone Strike Destroys Sudan Hospital, Cutting Care for 2 Million
A Sudanese army drone hit the El‑Daein Teaching Hospital in East Darfur, killing 70 people—including women, children and health workers—and wounding 146. The facility, which served more than two million residents, is now non‑functional, forcing patients to travel 160 km for...
Cuban Doctors Endure Burnout, Blackouts as Once-Vaunted Healthcare Declines
Cuban doctors, earning roughly $16 a month, are forced to take side jobs to survive. The public health system faces severe shortages, with a surgery waiting list projected to swell to 160,000 by year‑end and over 300 pediatric operations each...
Corcept Therapeutics Stock Jumps 19.7% After FDA Approves Lifyorli Combo
Corcept Therapeutics saw its shares climb almost 20% after the U.S. FDA gave the green light to Lifyorli in combination with nab‑paclitaxel for platinum‑resistant ovarian, fallopian tube and primary peritoneal cancers. The approval, based on a 381‑patient Rosella trial, validates...
World-First Living ‘Robots’ Develop Functional Nervous Systems
Researchers at the Wyss Institute have created the first living robots, called neurobots, that develop functional nervous systems from implanted neuronal precursor cells. The neurobots, built from frog embryonic cells, self‑organize neural networks that reshape their morphology, boost motility, and...